Could a common supplement prevent stomach tumors?
NCT ID NCT06272500
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether betaine hydrochloride, a dietary supplement, can safely lower high gastrin levels in people with autoimmune gastritis. High gastrin is linked to an increased risk of stomach tumors. Sixty participants will receive either betaine or a placebo before meals for up to three months. The goal is to see if this simple approach can reduce tumor risk.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- betaine hydrochloride
- What this could lead to
- If it works, this could offer a simple, low-cost way to lower gastrin levels and reduce the risk of stomach tumors in people with autoimmune gastritis.
- What could go wrong
- This is a small, early-phase trial with only 60 participants. The supplement may not lower gastrin effectively, and long-term benefits or risks are unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE GASTRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
First Affiliated Hospital of Zhengzhou University
RECRUITINGZhengzhou, Henan, 436400, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.